Adaptive Biotechnologies Corp — Director's Dealing 2019

Jun 27, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2019-06-26

Reporting Person: LO FRANCIS (Chief People Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.8	2029-05-06	Common Stock (200000)		Direct

Footnotes

F1: The options vest with respect to 1/4 of such shares on May 6, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.